Liver Fibrosis Current Events | Liver Fibrosis News | 3
|
| Page
3 of
34 |
668 Results |
|
|
|
Sort By:
Page Views | Date |
Researchers aim to cut future need for liver transplants
University of Edinburgh scientists have identified primitive liver cells —possibly dormant from the earliest developmental stage of a human being — which have the potential to mature into different cells types and help repair a failing liver. view more (2006-07-07)
Making headway against hepatitis C: SLU study shows new drug combo effective in non-responders
Saint Louis University Liver Center scientists are presenting research today on a more effective way to treat hepatitis C patients who have been unresponsive to current drug therapies. view more (2006-10-30)
Scientists discover basic defect in cystic fibrosis airway glands
Scientists at Stanford University have determined that the buildup of sticky mucus found in cystic fibrosis is caused by a loss in the epithelial cell's ability to secrete fluid. view more (2006-03-20)
Trial Reveals Safer And Simpler Approach To Treating Children With Cystic Fibrosis
Treating chest infections in young cystic fibrosis patients with an antibiotic once instead of three times daily is as effective and less toxic, conclude the results of a randomised trial published in this week's issue of THE LANCET. view more (2005-02-09)
Protein opens hope of treatment for cystic fibrosis patients
Scientists have finally identified a direct role for the missing protein that leaves cystic fibrosis patients open to attack from lung-damaging bacteria, the main reason most of them die before their 35th birthday, scientists heard today (Thursday 11 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at... view more... (2008-09-11)
Interferon does not slow or stop hepatitis C from worsening, study finds
Interferon does not slow or halt the progression of chronic hepatitis C and advanced liver disease in patients who haven't responded to previous attempts to eradicate the disease, a national study in which the Saint Louis University School of Medicine participated has found. view more (2007-11-09)
Is telmisartan effective in treating non-alcoholic steatohepatitis?
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are well-recognized causes of progressive liver disease leading to cirrhosis and hepatocellular carcinoma. view more (2009-03-03)
Key Found to Kill Cystic Fibrosis Superbug
Researchers from the Schulich School of Medicine & Dentistry at The University of Western Ontario , working with a group from Edinburgh, have discovered a way to kill the cystic fibrosis superbug, Burkholderia cenocepacia. view more (2007-04-25)
Cystic fibrosis treatments may have unseen long-term benefits
Cystic fibrosis medicines that help to break down mucus in the lungs may carry an unexpected long-term benefit, a study suggests. view more (2009-07-17)
Attention: Extra-hepatic manifestation of hepatitis C virus infection
In 1994, the team of Tchernev and Petrova from Alexandrovska Hospital in Sofia examined a female patient with liver cirrhosis caused by chronic Hepatitis C virus (HCV). view more (2008-01-17)
HBV genotype B/B3 and C/C1 are the major genotypes in Indonesia?
Previous studies revealed that HBV genotypes as well as mutations in the core promoter, precore or HBx gene have been shown to have an association with the clinical outcome of liver disease, however, this is still controversial. view more (2009-09-16)
Extending treatment after liver transplant may benefit patients with hepatitis C recurrence
Extending hepatitis C treatment for liver transplant patients beyond current practice results in high rates of clearance of the hepatitis C virus from the blood, as well as a low rate of relapse, according to a Henry Ford Hospital study. view more (2009-11-02)
Should living liver donation be available in the NHS?
Living liver donation should be available on the NHS, although it should not be adopted without full public debate and agreement because of the risks to donors, argue researchers in this week's BMJ. Living liver donation could benefit patients who are likely to die or deteriorate before a cadaveric donor becomes available. It involves a minimum... view more... (2003-09-17)
Preventing lung scarring may extend lives of lung cancer patients
Researchers have found that using a special type of drug called a pharmaceutical monoclonal antibody to block the integrin beta6-TGF-beta pathway prevents a serious side effect of radiation therapy for lung cancer patients - pulmonary fibrosis (scarring of the lungs), thereby extending patients' lives and improving their quality of life. view more (2007-10-30)
Research promising for cystic fibrosis
New U of T research holds promise for developing innovative therapies against cystic fibrosis and may also serve as a model for future therapies against the HIV virus. view more (2008-03-19)
UCSD researchers pave the way for effective liver treatments
A combination of bioengineering and medical research at the University of California, San Diego has led to a new discovery that could pave the way for more effective treatments for liver disease. view more (2009-10-12)
University of Ulster Innovation Aids Cystic Fibrosis Patients Worldwide
A new exercise technique developed by a University of Ulster physiotherapist is helping cystic fibrosis (CF) sufferers worldwide. The new exercise measuring technique, pioneered by Dr Judy Bradley, a lecturer/practitioner in physiotherapy at the University' of Ulster, is to be discussed by Europe's top clinicians and researchers at a conference... view more... (2003-05-23)
That '4 hour erection': new discovery may help prevent a complication of priapism
For men coping with painful erections lasting for long periods of time, or priapism, new research published online in The FASEB Journal (http://www.fasebj.org) offers hope. view more (2009-10-27)
Bone marrow cells can become functional gut lining cells
Researchers report the discovery that cells used in bone marrow transplantation can develop into new cells lining the gut, according to a study by Yale School of Medicine in the Proceedings of the National Academy of Sciences. view more (2006-03-03)
Hyperferritinemia is another surrogate marker of advanced liver disease
High serum ferritin, being a hallmark of hereditary hemochromatosis , is frequently found in chronic hepatitis C, alcoholic or non-alcoholic steatohepatitis and non-alcoholic fatty liver disease patients. view more (2009-05-13)
|
|
| Page
3 of
34 |
668 Results |
|
|
|
Sort By:
Page Views | Date |
|
